| 50458-941-01 |
50458-941 |
HUMAN PRESCRIPTION DRUG |
INVOKAMET XR |
canagliflozin and metformin hydrochloride |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20160920 |
N/A |
NDA |
NDA205879 |
Janssen Pharmaceuticals, Inc. |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
50 mg/1; 1000 mg/1 |
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-941-01) |
| 50458-942-01 |
50458-942 |
HUMAN PRESCRIPTION DRUG |
INVOKAMET XR |
canagliflozin and metformin hydrochloride |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20160920 |
N/A |
NDA |
NDA205879 |
Janssen Pharmaceuticals, Inc. |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
150 mg/1; 500 mg/1 |
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-942-01) |
| 50458-943-01 |
50458-943 |
HUMAN PRESCRIPTION DRUG |
INVOKAMET XR |
canagliflozin and metformin hydrochloride |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20160920 |
N/A |
NDA |
NDA205879 |
Janssen Pharmaceuticals, Inc. |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
150 mg/1; 1000 mg/1 |
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-943-01) |
| 50458-940-01 |
50458-940 |
HUMAN PRESCRIPTION DRUG |
INVOKAMET XR |
canagliflozin and metformin hydrochloride |
TABLET, FILM COATED, EXTENDED RELEASE |
ORAL |
20160920 |
N/A |
NDA |
NDA205879 |
Janssen Pharmaceuticals, Inc. |
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDE |
50 mg/1; 500 mg/1 |
60 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (50458-940-01) |